Y Tomita

575 total citations
25 papers, 467 citations indexed

About

Y Tomita is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, Y Tomita has authored 25 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Y Tomita's work include Cervical Cancer and HPV Research (6 papers), Virus-based gene therapy research (5 papers) and T-cell and Retrovirus Studies (4 papers). Y Tomita is often cited by papers focused on Cervical Cancer and HPV Research (6 papers), Virus-based gene therapy research (5 papers) and T-cell and Retrovirus Studies (4 papers). Y Tomita collaborates with scholars based in Japan and United States. Y Tomita's co-authors include Hiroshi Shirasawa, B. Simizu, H Takamizawa, Souei Sekiya, T. Kuwata, Tomoyuki Imai, Masahiro Kimura, Koichi Kubota, Akira Fuse and S Sekiya and has published in prestigious journals such as Journal of Virology, International Journal of Molecular Sciences and Annals of the New York Academy of Sciences.

In The Last Decade

Y Tomita

24 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Tomita Japan 11 294 171 111 98 95 25 467
Roland Degenkolbe Singapore 5 219 0.7× 153 0.9× 149 1.3× 82 0.8× 69 0.7× 5 356
G Pecoraro United States 9 177 0.6× 118 0.7× 103 0.9× 73 0.7× 172 1.8× 13 412
Kersten T. Hall United Kingdom 13 285 1.0× 90 0.5× 275 2.5× 67 0.7× 40 0.4× 21 474
Donna Hempel United States 10 111 0.4× 153 0.9× 126 1.1× 156 1.6× 163 1.7× 14 471
Sara Jackson United States 14 256 0.9× 86 0.5× 113 1.0× 126 1.3× 56 0.6× 28 626
Irene Kraus Norway 11 771 2.6× 366 2.1× 130 1.2× 57 0.6× 55 0.6× 14 927
Nils Forsby Sweden 12 123 0.4× 71 0.4× 235 2.1× 74 0.8× 37 0.4× 19 456
Takuto Miyamura Japan 12 208 0.7× 280 1.6× 44 0.4× 120 1.2× 41 0.4× 34 623
T Shibuya Japan 12 82 0.3× 113 0.7× 89 0.8× 129 1.3× 183 1.9× 30 568
Robert Saiz United States 8 95 0.3× 202 1.2× 97 0.9× 198 2.0× 130 1.4× 9 487

Countries citing papers authored by Y Tomita

Since Specialization
Citations

This map shows the geographic impact of Y Tomita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Tomita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Tomita more than expected).

Fields of papers citing papers by Y Tomita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Tomita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Tomita. The network helps show where Y Tomita may publish in the future.

Co-authorship network of co-authors of Y Tomita

This figure shows the co-authorship network connecting the top 25 collaborators of Y Tomita. A scholar is included among the top collaborators of Y Tomita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Tomita. Y Tomita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tomita, Y, Sachiko Ishibashi, Masumi Ikeda, et al.. (2024). GPX4 and FSP1 Expression in Lung Adenocarcinoma: Prognostic Implications and Ferroptosis-Based Therapeutic Strategies. Cancers. 16(22). 3888–3888. 3 indexed citations
3.
Tamura, Kazuhiro, Y Tomita, Sachiko Ishibashi, et al.. (2024). Lipid Peroxidation Regulators GPX4 and FSP1 as Prognostic Markers and Therapeutic Targets in Advanced Gastric Cancer. International Journal of Molecular Sciences. 25(17). 9203–9203. 6 indexed citations
4.
Ito, Takashi, Kouhei Yamamoto, Asuka Furukawa, et al.. (2023). Invasive features of superficial oesophageal squamous cell carcinoma—analysis of risk factors for lymph node metastasis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(5). 645–653. 1 indexed citations
5.
Tomita, Y. (2011). Hermite's formulas for $q$-analogues of Hurwitz zeta functions. Functiones et Approximatio Commentarii Mathematici. 45(2). 3 indexed citations
6.
Okano, Shinji, Yoshikazu Yonemitsu, Shigekazu Nagata, et al.. (2003). Recombinant Sendai virus vectors for activated T lymphocytes. Gene Therapy. 10(16). 1381–1391. 23 indexed citations
7.
Tomita, Y, Yasuhiro Asano, & Hiroshi Shirasawa. (1998). Trans-activating activity of the E6 proteins of the human papillomavirus (HPV) type-11 and -16 on the PE1E4 promoter of HPV-11 in C33A cells.. International Journal of Oncology. 13(6). 1253–8. 1 indexed citations
8.
Takeda, Masayuki, Kozue Saito, Takaki Mizusawa, et al.. (1997). Plasma endothelin-1 level in patients with renovascular hypertension - does the kidney with stenosis of the renal artery upregulate production of endthelin-1?. PubMed. 2(7). 315–20. 3 indexed citations
10.
Tsuchihashi, Takuya, Yasuyuki Takata, Y Tomita, et al.. (1992). Chronic Cardiovascular Effects of Central Vasopressin in Conscious Rats. Clinical and Experimental Hypertension Part A Theory and Practice. 14(4). 699–716. 4 indexed citations
11.
Shirasawa, Hiroshi, Y Tomita, Akira Fuse, et al.. (1989). Structure and Expression of an Integrated Human Papillomavirus Type 16 Genome Amplified in a Cervical Carcinoma Cell Line. Journal of General Virology. 70(7). 1913–1919. 31 indexed citations
12.
Shirasawa, Hiroshi, et al.. (1988). Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas. Journal of Virology. 62(3). 1022–1027. 89 indexed citations
13.
Onoyama, Kaoru, Ikuro Abe, Shuichi Takishita, et al.. (1987). Pathophysiology in malignant hypertension: With special reference to the renin‐angiotensin system. Clinical Cardiology. 10(9). 513–518. 9 indexed citations
14.
Muratani, H., Isao Abe, Y Tomita, et al.. (1987). Single Oral Administration of Captopril may not bring an Improvement in Screening of Primary Aldosteronism. Clinical and Experimental Hypertension Part A Theory and Practice. 9(2-3). 611–614. 5 indexed citations
16.
Shirasawa, Hiroshi, Y Tomita, Souei Sekiya, H Takamizawa, & B. Simizu. (1987). Integration and Transcription of Human Papillomavirus Type 16 and 18 Sequences in Cell Lines Derived from Cervical Carcinomas. Journal of General Virology. 68(2). 583–591. 112 indexed citations
17.
Sekiya, Souei, et al.. (1986). Effects of human interferons on human choriocarcinoma cells in vitro and in vivo. Gynecologic Oncology. 25(1). 115–124. 8 indexed citations
18.
Tomita, Y & T. Kuwata. (1981). Suppressive Effects of Interferon on Cell Fusion by Sendai Virus. Journal of General Virology. 55(2). 289–295. 13 indexed citations
19.
Tomita, Y & T. Kuwata. (1980). INTERFERON INHIBITS CELL FUSION BY SENDAI VIRUS. Annals of the New York Academy of Sciences. 350(1). 625–625. 2 indexed citations
20.
Tomita, Y & T. Kuwata. (1979). Suppressive Effects of Interferon on Syncytium Formation by RD-114 Virus in Human Transformed Cells. Journal of General Virology. 43(1). 111–117. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026